NYSE · CIK 0001613103 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Medtronic plc
MDT chart by TradingView
PRICE HISTORY
LIVE · NYSEMDT chart by TradingView
- REVENUE FY2026 ENDED APR 2026
- $36.4B
- EBITDA
- $9.4B
- FREE CASH FLOW
- $5.4B
- EPS
- $3.73
- GROSS MARGIN
- 65.02%
- ROIC
- 9.74%
Q4 FY26ENDED APR 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
22.4x
-34%22.1x54.0x
⤢
P / SALES (TTM)
3.0x
-31%2.9x5.9x
⤢
P / BOOK
2.2x
-10%1.8x3.5x
⤢
EV / EBITDA (TTM)
11.4x
-23%11.2x24.2x
⤢
EV / REVENUE (TTM)
3.0x
-31%2.9x5.8x
⤢
FCF YIELD (TTM)
5.05%
+1.2pp2.75%5.05%
⤢
DIVIDEND YIELD (TTM)
3.41%
+1.6pp1.77%3.95%
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$9.8B
+37%⤢
EBITDA (DERIVED)
$2.6B
+36%⤢
NET INCOME
$1.2B
+34%⤢
EPS (DILUTED)
$0.96
+46%⤢
REVENUE GROWTH YOY
9.87%
+11.4pp-26.38%36.53%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
21.26%
+4.2pp-0.86%27.39%
⤢
RETURN ON CAPITAL
9.74%
+2.4pp4.26%9.84%
⤢
RETURN ON EQUITY (TTM)
9.71%
+2.5pp4.56%10.26%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN65.35%
OPERATING MARGIN19.09%
NET MARGIN12.68%
FCF MARGIN21.26%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$2.1B
+71%⤢
STOCK-BASED COMP
$0.1B
+20%⤢
CAPITAL EXPENDITURE
$0.5B
+48%⤢
SHARES OUTSTANDING
1.29B
-8%⤢
DIVIDEND / SHARE
$0.71
+65%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$1.9B
-36%⤢
TOTAL DEBT
$1.8B
-8%⤢
DEBT / EBITDA (TTM)
0.2x
-20%0.0x4.0x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 90.13%INSIDERS 0.31%OTHER / RETAIL 9.56%2,924 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 8.84% | 113.2M | $9.86B | -6.1% |
| Vanguard Capital Management LLC | 6.51% | 83.3M | $7.26B | NEW |
| State Street Corporation | 4.82% | 61.7M | $5.38B | +0.1% |
| JPMORGAN CHASE & CO | 3.98% | 51.0M | $4.44B | -4.9% |
| Capital Research Global Investors | 3.28% | 41.9M | $3.65B | +21.3% |
| Vanguard Portfolio Management LLC | 2.61% | 33.5M | $2.92B | NEW |
| Geode Capital Management, LLC | 2.24% | 28.7M | $2.50B | +3.1% |
| Bank of America Corporation | 2.03% | 26.0M | $2.27B | +5.4% |
| Morgan Stanley | 1.62% | 20.7M | $1.81B | +2.5% |
| Massachusetts Financial Services Co. | 1.55% | 19.9M | $1.73B | -7.3% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.